Platform Therapeutics

Seed
ptx.life Biotech & Healthcare Andover, United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Aug 27, 2026
Investors Undisclosed
Decision Makers Profile Active

About Platform Therapeutics

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Andover, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website ptx.life
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Platform Therapeutics.

Funding History

1 Round
Seed · Aug 27, 2026
Undisclosed

Founders & Leadership

3

Arthur Atkinson

Founder & CSO

Work email & phone locked Unlock →

James Wilkie

Founder & CEO

Work email & phone locked Unlock →

Lakhmir Chawla

Founder, Chairman, & CMO

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts